Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question
- PMID: 29459427
- DOI: 10.1136/annrheumdis-2017-212588
Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question
Keywords: corticosteroids; infections; rheumatoid arthritis.
Conflict of interest statement
Competing interests: KLW has been a consultant and/or investigator for Pfizer, AbbVie, Lilly, BMS, Galapagos and UCB. JWB has been a consultant for Pfizer, Merck and R-Pharm.
Comment on
-
Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids.Ann Rheum Dis. 2018 May;77(5):644-649. doi: 10.1136/annrheumdis-2017-211796. Epub 2017 Nov 1. Ann Rheum Dis. 2018. PMID: 29092853 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
